Ownership history in Parallel Advisors, LLC · 18 quarters on record
This page tracks every 13F SEC filing in which Parallel Advisors, LLC reported a position in ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 250 | — | 0% | 0.00% | $33 | — |
| 2025 Q2 | UNCHANGED | 250 | — | 0% | 0.00% | $60 | — |
| 2025 Q1 | UNCHANGED | 250 | — | 0% | 0.00% | $49 | — |
| 2024 Q4 | REDUCED | 250 | -6,933 | -96.5% | 0.00% | $135 | — |
As of 2025 Q4 — sorted by position size